Marksans Pharma Ltd
Marksans Pharma is engaged in Business of Formulation of pharmaceutical products.
- Market Cap ₹ 2,415 Cr.
- Current Price ₹ 59.0
- High / Low ₹ 66.2 / 9.85
- Stock P/E 36.6
- Book Value ₹ 13.4
- Dividend Yield 0.17 %
- ROCE 11.4 %
- ROE 7.76 %
- Face Value ₹ 1.00
Pros
- Company has reduced debt.
- Company is almost debt free.
- Company is expected to give good quarter
Cons
- Stock is trading at 4.41 times its book value
- Company has a low return on equity of 6.90% for last 3 years.
Peer comparison
Sector: Pharmaceuticals Industry: Pharmaceuticals - Indian - Bulk Drugs
Quarterly Results
Standalone Figures in Rs. Crores / View Consolidated
Dec 2017 | Mar 2018 | Jun 2018 | Sep 2018 | Dec 2018 | Mar 2019 | Jun 2019 | Sep 2019 | Dec 2019 | Mar 2020 | Jun 2020 | Sep 2020 | |
---|---|---|---|---|---|---|---|---|---|---|---|---|
80 | 87 | 93 | 115 | 125 | 91 | 92 | 101 | 117 | 114 | 156 | 138 | |
69 | 76 | 76 | 97 | 108 | 88 | 82 | 88 | 97 | 95 | 127 | 115 | |
Operating Profit | 12 | 11 | 17 | 18 | 17 | 3 | 10 | 13 | 20 | 18 | 29 | 23 |
OPM % | 14% | 12% | 18% | 16% | 14% | 4% | 11% | 13% | 17% | 16% | 19% | 17% |
Other Income | 0 | 0 | 3 | 3 | 0 | 10 | 2 | 8 | 0 | -0 | 0 | 13 |
Interest | 1 | 3 | 2 | 2 | 1 | 2 | 2 | 2 | 1 | 2 | 1 | 1 |
Depreciation | 3 | 3 | 2 | 2 | 2 | 2 | 3 | 3 | 3 | 3 | 3 | 4 |
Profit before tax | 8 | 6 | 17 | 17 | 14 | 9 | 8 | 16 | 16 | 13 | 25 | 31 |
Tax % | 27% | 24% | 17% | 25% | 16% | 36% | 28% | 24% | 19% | 44% | 11% | 24% |
Net Profit | 6 | 4 | 14 | 12 | 12 | 6 | 6 | 12 | 13 | 7 | 22 | 24 |
EPS in Rs | 0.14 | 0.11 | 0.34 | 0.30 | 0.29 | 0.14 | 0.14 | 0.29 | 0.32 | 0.18 | 0.54 | 0.57 |
Notes | Notes | Notes | Notes | Notes | Notes | Notes | Notes | Notes | Notes | Notes | Notes |
Profit & Loss
Standalone Figures in Rs. Crores / View Consolidated
Mar 2009 | Mar 2010 | Mar 2011 | Mar 2012 | Mar 2013 | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | TTM | |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|
200 | 200 | 155 | 155 | 192 | 315 | 406 | 358 | 216 | 295 | 424 | 433 | 524 | |
179 | 176 | 235 | 272 | 148 | 231 | 290 | 254 | 191 | 266 | 361 | 362 | 433 | |
Operating Profit | 20 | 24 | -81 | -118 | 44 | 84 | 116 | 104 | 24 | 29 | 63 | 71 | 91 |
OPM % | 10% | 12% | -52% | -76% | 23% | 27% | 29% | 29% | 11% | 10% | 15% | 16% | 17% |
Other Income | 7 | 1 | -79 | 2 | 4 | 3 | 3 | 9 | 7 | 7 | 8 | 0 | 13 |
Interest | 15 | 15 | 39 | 49 | 10 | 15 | 13 | 6 | 4 | 8 | 7 | 7 | 5 |
Depreciation | 10 | 10 | 15 | 18 | 9 | 9 | 9 | 15 | 15 | 12 | 9 | 12 | 13 |
Profit before tax | 2 | 1 | -213 | -183 | 30 | 63 | 97 | 92 | 12 | 17 | 56 | 53 | 85 |
Tax % | 79% | 54% | -2% | 1% | -34% | 12% | 31% | 22% | 3% | 25% | 22% | 28% | |
Net Profit | 0 | 0 | -218 | -181 | 40 | 56 | 67 | 71 | 12 | 12 | 44 | 38 | 66 |
EPS in Rs | 1.03 | 1.44 | 1.64 | 1.75 | 0.28 | 0.30 | 1.07 | 0.93 | 1.61 | ||||
Dividend Payout % | 0% | 0% | 0% | 0% | 0% | 7% | 7% | 7% | 18% | 16% | 5% | 11% |
Compounded Sales Growth | |
---|---|
10 Years: | 8% |
5 Years: | 1% |
3 Years: | 26% |
TTM: | 28% |
Compounded Profit Growth | |
---|---|
10 Years: | 60% |
5 Years: | -11% |
3 Years: | 49% |
TTM: | 89% |
Stock Price CAGR | |
---|---|
10 Years: | 34% |
5 Years: | 1% |
3 Years: | 9% |
1 Year: | 192% |
Return on Equity | |
---|---|
10 Years: | % |
5 Years: | 8% |
3 Years: | 7% |
Last Year: | 8% |
Balance Sheet
Standalone Figures in Rs. Crores / View Consolidated
Mar 2009 | Mar 2010 | Mar 2011 | Mar 2012 | Mar 2013 | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Sep 2020 | |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|
50 | 50 | 50 | 50 | 52 | 52 | 53 | 53 | 41 | 41 | 41 | 41 | 41 | |
Reserves | 109 | 125 | -92 | -240 | 58 | 108 | 305 | 369 | 378 | 388 | 430 | 465 | 506 |
Borrowings | 319 | 353 | 103 | 100 | 91 | 89 | 50 | 41 | 73 | 67 | 78 | 0 | 0 |
62 | 60 | 359 | 345 | 123 | 141 | 132 | 83 | 54 | 61 | 64 | 88 | 143 | |
Total Liabilities | 526 | 575 | 407 | 243 | 310 | 376 | 527 | 534 | 546 | 557 | 612 | 594 | 690 |
279 | 294 | 185 | 77 | 73 | 67 | 90 | 97 | 94 | 88 | 103 | 115 | 124 | |
CWIP | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Investments | 68 | 78 | 68 | 24 | 68 | 68 | 68 | 231 | 234 | 236 | 236 | 236 | 236 |
180 | 204 | 154 | 142 | 170 | 242 | 369 | 205 | 217 | 233 | 273 | 243 | 331 | |
Total Assets | 526 | 575 | 407 | 243 | 310 | 376 | 527 | 534 | 546 | 557 | 612 | 594 | 690 |
Cash Flows
Standalone Figures in Rs. Crores / View Consolidated
Mar 2009 | Mar 2010 | Mar 2011 | Mar 2012 | Mar 2013 | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | |
---|---|---|---|---|---|---|---|---|---|---|---|---|
89 | 12 | -68 | -61 | 9 | 54 | 112 | 65 | -14 | 16 | 20 | 118 | |
-142 | -34 | 26 | 41 | -48 | -2 | -29 | -177 | -8 | -8 | -20 | -24 | |
22 | 42 | 36 | 11 | 22 | -19 | 51 | -52 | 21 | -10 | 1 | -92 | |
Net Cash Flow | -30 | 20 | -6 | -9 | -17 | 33 | 134 | -164 | -1 | -2 | 1 | 2 |
Ratios
Standalone Figures in Rs. Crores / View Consolidated
Mar 2009 | Mar 2010 | Mar 2011 | Mar 2012 | Mar 2013 | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | |
---|---|---|---|---|---|---|---|---|---|---|---|---|
ROCE % | 4% | 3% | -32% | 71% | 35% | 33% | 22% | 3% | 5% | 12% | 11% | |
Debtor Days | 93 | 123 | 170 | 175 | 174 | 130 | 112 | 136 | 262 | 209 | 153 | 136 |
Inventory Turnover | 1.25 | 1.67 | 1.81 | 2.28 | 2.34 | 3.29 | 4.24 | 3.92 | 3.27 | 4.93 | 4.34 | 3.47 |
Documents
Add documentRecent announcements
- Shareholding for the Period Ended December 31, 2020 2d
- Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018 12 Jan
- Statement Of Investor Complaints For The Quarter Ended December 2020 9 Jan
- Closure of Trading Window 31 Dec
- Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Outcome 25 Nov 2020
View all
Annual reports
- Financial Year 2020 from bse
- Financial Year 2019 from bse
- Financial Year 2018 from bse
- Financial Year 2017 from bse
- Financial Year 2016 from bse
- Financial Year 2015 from bse
- Financial Year 2014 from bse
- Financial Year 2013 from bse
- Financial Year 2013 from nse
- Financial Year 2012 from bse
- Financial Year 2011 from bse
- Financial Year 2011 from nse
- Financial Year 2010 from bse
- Financial Year 2010 from nse